Vulnerable Plaque Diagnosis, Treatment: Is Enrollment “Impossible”?

Diagnostic modalities and therapies for vulnerable plaque should be tested simultaneously in one clinical trial to ensure the enrollment size is manageable, according to cardiac researcher James Muller, MD, Massachusetts General Hospital